Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.730
-0.100 (-2.07%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2701147850313505
Market Cap Growth
246.77%46.66%56.96%-84.17%-37.97%-
Enterprise Value
80-4916-68132344
Last Close Price
4.732.423.152.0212.8324.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-15.962.992.0320.57450.53
PB Ratio
1.470.841.480.471.983.70
P/TBV Ratio
1.470.841.480.471.983.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--0.62-8.66306.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.020.010.010.00
Net Debt / Equity Ratio
-1.04-1.07-0.88-1.02-1.08-1.09
Net Debt / EBITDA Ratio
2.211.270.721.502.914.01
Net Debt / FCF Ratio
2.741.490.761.693.416.60
Asset Turnover
-0.070.260.150.090.01
Inventory Turnover
--9.2112.49--
Quick Ratio
17.1610.043.114.339.269.76
Current Ratio
17.3810.263.594.729.569.90
Return on Equity (ROE)
-44.98%-21.82%-80.79%-49.90%-41.06%-177.60%
Return on Assets (ROA)
-28.70%-64.66%-39.96%-28.39%-21.54%-26.21%
Return on Capital Employed (ROCE)
-47.00%-83.90%-121.70%-67.80%-35.60%-26.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-29.61%-18.06%-81.90%-132.75%-19.33%-21.82%
FCF Yield
-25.72%-85.91%-78.71%-128.45%-16.00%-4.45%
Buyback Yield / Dilution
-78.42%-128.96%-0.42%-19.58%-152.27%-250.99%
SEC Filings: 10-K · 10-Q